Novel GLP-1/GIP Agent Led to Weight Loss With Once-Monthly Dosing

(MedPage Today) — CHICAGO — An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with obesity with or without type 2 diabetes, a phase II randomized trial showed.
In the obesity…